Zenas Biopharma Inc
ZBIO16.810USD
+1.400+9.09%
Close 08/04, 16:00（ET）Quotes delayed by 15 min
16.630USD+16.630After-hours (ET)
703.03MMarket Cap
LossP/E TTM
Zenas Biopharma Inc
16.810
+1.400+9.09%
Quarterly
Quarterly+Annual
Quarterly
Annual
YOY
Hide blank rows
FY2025Q1
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023Q4
FY2023Q3
Total equity
Cash, cash equivalents and short-term investments
745.71%314.21M
516.93%350.77M
434.91%386.80M
--183.93M
--37.15M
--56.86M
--72.31M
- Cash and cash equivalents
745.71%314.21M
462.36%319.74M
397.90%360.04M
--183.93M
--37.15M
--56.86M
--72.31M
-Short-term investments
--115.83M
--31.02M
--26.76M
----
----
----
----
Prepaid expenses
112.78%5.43M
71.94%5.07M
59.89%6.98M
--4.67M
--2.55M
--2.95M
--4.37M
Other current assets
--0.00
--90.00K
----
----
----
----
----
Total current assets
700.42%317.81M
495.15%355.92M
413.56%393.78M
--188.60M
--39.70M
--59.80M
--76.68M
Non-current assets
Net Fixed Assets
50.65%1.28M
17.26%1.19M
-52.48%545.00K
--706.00K
--847.00K
--1.01M
--1.15M
Long-term prepaid expenses
118.37%12.64M
--12.64M
--8.92M
--6.77M
--5.79M
----
----
Other non-current assets
3061.25%268.68M
74.63%12.86M
52.61%9.11M
--10.65M
--8.50M
--7.36M
--5.97M
Total non-current assets
70.76%15.96M
67.68%14.04M
35.67%9.65M
--11.35M
--9.35M
--8.38M
--7.12M
Total assets
580.45%333.77M
442.63%369.97M
381.47%403.43M
--199.95M
--49.05M
--68.18M
--83.79M
Liabilities
Current liabilities
-Other payables
----
----
----
--530.00K
--1.50M
----
----
Accrued expenses
46.99%28.20M
126.28%39.16M
124.69%28.53M
--29.73M
--19.19M
--17.31M
--12.70M
Other current liabilities
----
----
----
--530.00K
--1.50M
----
----
Total current liabilities
61.98%49.13M
146.33%57.29M
182.81%44.00M
--39.11M
--30.33M
--23.26M
--15.56M
Non-current liabilities
Long-term debt and lease liabilities
-98.50%317.00K
-98.94%218.00K
-100.00%0.00
--14.00K
--21.13M
--20.56M
--20.38M
-Long-term debt
----
-100.00%0.00
-100.00%0.00
--0.00
--20.99M
--20.30M
--20.00M
-Long-term lease liabilities
138.35%317.00K
-15.18%218.00K
-100.00%0.00
--14.00K
--133.00K
--257.00K
--381.00K
Total non-current liabilities
-98.50%317.00K
-98.94%218.00K
-100.00%0.00
--14.00K
--21.13M
--20.56M
--20.38M
Total liabilities
-3.91%49.45M
31.26%57.51M
22.42%44.00M
--39.12M
--51.46M
--43.81M
--35.94M
Shareholders' equity
Common equity
12415.80%705.14M
14962.54%699.65M
19962.63%694.17M
--7.29M
--5.63M
--4.64M
--3.46M
Preferred equity
----
----
----
--449.61M
--250.09M
--250.09M
--250.09M
Retained earnings
-63.04%-420.96M
-68.14%-387.39M
-62.66%-334.79M
---296.18M
---258.20M
---230.40M
---205.82M
Capital reserves
12417.95%705.14M
14962.45%699.65M
19968.31%694.16M
--7.29M
--5.63M
--4.64M
--3.46M
Gains losses not affecting retained earnings
90.54%141.00K
424.32%194.00K
-56.45%54.00K
--104.00K
--74.00K
--37.00K
--124.00K
Total equity
11902.28%284.32M
1182.41%312.46M
651.11%359.44M
--160.83M
---2.41M
--24.36M
--47.85M
Currency unit
USD
USD
USD
USD
USD
USD
USD
Audit opinions
--
--
--
--
--
--
--
